JB Chemicals & Pharmaceuticals Profit & Loss Annual

Trade
BSE: 506943 | NSE: JBCHEPHARM | ISIN: INE572A01036 | Sector: Biotechnology & Drugs
1,750.80 +16.60 (0.96%)Updated : 25 Nov 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 3,484.183,149.282,424.242,042.52
Total Revenue 3,484.183,149.282,424.242,042.52
Costof Revenue Total 1,182.051,276.34934.85780.04
Gross Profit 2,302.131,872.941,489.401,262.48
Selling/ General/ Admin Expenses Total 601.411,093.90881.68635.92
Depreciation/ Amortization 138.32114.4172.6668.67
Other Operating Expenses Total 803.8372.2060.4670.39
Total Operating Expense 2,725.612,556.851,949.651,555.01
Operating Income 758.57592.43474.60487.51
Interest Inc( Exp) Net- Non- Op Total -443.30-325.74293.17547.45
Other Net 37.27-4.63-1.422.19
Net Income Before Taxes 751.51555.23504.90596.89
Provisionfor Income Taxes 198.88145.23118.86148.36
Net Income After Taxes 552.63410.01386.04448.52
Minority Interest 0.00-0.17-0.68-0.56
Net Income Before Extra Items 552.63409.84385.36447.96
Net Income 552.63409.84385.36447.96
Income Availableto Com Excl Extra Ord 552.63409.84385.36447.96
Income Availableto Com Incl Extra Ord 552.63409.84385.36447.96
Diluted Net Income 552.63409.84385.36447.96
Diluted Weighted Average Shares 15.8615.6615.4715.46
Diluted EPS Excluding Extra Ord Items 34.8526.1724.9128.98
Diluted Normalized EPS 34.8526.1724.7926.43
Gain( Loss)on Saleof Assets -0.0724.05524.37
DPS- Common Stock Primary Issue -8.888.258.25
Unusual Expense( Income) ---0.00
*All figures in crores except per share values
Recommended For You
Trending Stocks
3,753.25+148.70(4.13%)
1,784.60+38.65(2.21%)
1,733.95-13.75 (-0.79%)
2,460.60-18.40 (-0.74%)
HomeMarketsPremiumInstant LoanMint Shorts